Intelligent Bio secures major drug testing tender with transport operator

Intelligent Bio Solutions (INBS) announced it has secured a major contract with one of London’s largest public transport operators, spanning 14 operational sites in greater London and employing over 4,400 staff. “Winning this tender says a lot about the strength of our technology,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “We offer a system that supports rapid drug testing at scale, meaning less people out of action for less time. This minimizes financial loss associated with long wait times and improves overall workforce efficiency. The rapidly rising popularity of our solution is testament to the many benefits it offers businesses of all sizes; from a greater suggestion of impairment and reduced risk to cost savings and a more dignified approach.”